Literature DB >> 8259506

How p53 suppresses cell growth.

J Marx.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8259506     DOI： 10.1126/science.8259506

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  23 in total

1.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.

Authors:  Christian Melle; Heinz-Peter Nasheuer
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

Review 3.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

Review 4.  Transcription factor-based drug design in anticancer drug development.

Authors:  A G Papavassiliou
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

Review 5.  The role of apoptosis in intestinal disease.

Authors:  A J Watson
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

6.  Distribution of the p53 pseudogene among mouse species and subspecies.

Authors:  H Tanooka; A Ootsuyama; T Shiroishi; K Moriwaki
Journal:  Mamm Genome       Date:  1995-05       Impact factor: 2.957

7.  Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.

Authors:  M Ohkoudo; H Sawa; M Hara; K Saruta; T Aiso; R Ohki; H Yamamoto; E Maemura; Y Shiina; M Fujii; I Saito
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

8.  p53 and p16INK4A mutations during the progression of glomus tumor.

Authors:  S Güran; E T Tali
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

9.  Cytotoxic T cell immunity against telomerase reverse transcriptase in humans.

Authors:  B Minev; J Hipp; H Firat; J D Schmidt; P Langlade-Demoyen; M Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

10.  Analysis of p53 mutations and Helicobacter pylori infection in human and animal models.

Authors:  Kazunari Murakami; Toshio Fujioka; Masaaki Kodama; Shoji Honda; Tadayoshi Okimoto; Touta Oda; Akira Nishizono; Ryugo Sato; Toshihiro Kubota; Jiro Kagawa; Masaru Nasu
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.